Eckert & Ziegler Strahlen und Medizintechnik (EUZ) AI Stock Analysis

Eckert & Ziegler Strahlen und Medizintechnik

(BX Swiss:EUZ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong ProfitabilityStrong gross, operating, and net margins indicate that the company converts revenue into profit efficiently across its medical technology and isotope activities. Sustained profitability supports internal reinvestment, resilience against operating pressure, and the ability to fund growth without relying heavily on external capital.

Negative Factors

Softening Revenue GrowthThe recent TTM revenue decline suggests that the company’s top-line momentum has softened after several years of expansion. If this persists, slower growth could limit operating leverage, reduce the pace of earnings expansion, and make continued margin performance more dependent on execution.

Eckert & Ziegler Strahlen und Medizintechnik (EUZ) vs. iShares MSCI Switzerland ETF (EWL)

Market Cap: CHF 67.95M
Dividend Yield: 1.77%
Average Volume (3M): 859
Price to Earnings (P/E): 16.6
Beta (1Y): 0.90
Revenue Growth: 2.56%
EPS Growth: 33.38%
Country: Switzerland
Employees: 1,105
Sector: General
Sector Strength: 55
Industry: Medical - Specialties

Eckert & Ziegler Strahlen und Medizintechnik Business Overview & Revenue Model

Company Description

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of pro...

Eckert & Ziegler Strahlen und Medizintechnik Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

CH:EUZ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:SHL	70Outperform	EUR 47.86B	21.66	12.00%	2.33%	-0.92%	2.06%
DE:M3V	68Neutral	EUR 37.13M	26.84	7.77%	4.66%	-6.92%	-67.82%
DE:SBS	57Neutral	EUR 273.51M	-562.50	-0.17%	2.67%	―	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
DE:GXI	52Neutral	EUR 1.11B	-2.76	-32.84%	0.12%	8.90%	-609.05%

* General Sector Average

Performance Comparison

CH:EUZ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CH:EUZ	Eckert & Ziegler Strahlen und Medizintechnik	11.56	-1.20	-9.37%
DE:GXI	Gerresheimer AG	32.04	6.06	23.33%
DE:M3V	MeVis Medical Solutions	20.40	-3.89	-16.00%
DE:SBS	STRATEC Biomedical	22.50	0.99	4.62%
DE:SHL	Siemens Healthineers	42.89	-5.20	-10.82%
DE:MF6	MagForce AG	―	―	―

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Eckert & Ziegler Strahlen und Medizintechnik AI Stock Analysis